C-[5-(3-Trifluoromethoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-methylamine; hydrochloride, 95.0%, 1g

Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate, 97%, 1g

Ethyl 3-ethoxypropanoate, 95.0%, 25ml

Ocular HWF 10x/21 mm con punto de mira

2,6-Dibromo-4-nitro-pyridine, 97.0%, 25g

Triacetoxymanganese dihydrate, 95.0%, 10g

3-Bromo-4-methylbenzonitrile, 95.0%, 500g

4-Bromo-3,5-dimethylpyridine, 95.0%, 5g

Isopropyl 3-oxobutanoate, 97%, 100g

1-Benzyl 2-(tert-butyl) hydrazine-1,2-dicarboxylate, 95.0%, 10g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chloro-2-fluorophenyl)propanoic acid, 97%, 1g

(+/-)-10-Camphorsulfonic Acid>98.0%(T)25g

4-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g